02/28
Headlines

NASDAQ:DYAX

Biotech Gainers In News: Inovio Pharmaceuticals (NYSEMKT:INO), Dendreon Corporation (NASDAQ:DNDN), BioCryst Pharmaceuticals (NASDAQ:BCRX), Dyax (NASDAQ:DYAX)

Colin Pettis02 mins

Inovio Pharmaceuticals Inc (NYSEMKT:INO) on Feb. 27 announced the pricing of an underwritten public offering of 18,966,000 shares of common stock for a public offering price of $2.90 per share. The gross proceeds to Inovio from this offering are expected to be approximately $55 million, before deducting the underwriting discounts and commissions and other estimated…

Read More

Momentum Stocks : Southwest Airlines (NYSE:LUV), Dyax Corp. (NASDAQ:DYAX), Fossil Group (NASDAQ:FOSL), YY Inc. (NASDAQ:YY), Sony Corp (ADR) (NYSE:SNE)

John Meady02 mins

Southwest Airlines Co. (NYSE:LUV) Chief Executive Officer Gary Kelly said, “I don’t see the need to do anything differently.” While Southwest doesn’t fly beyond the Caribbean and Mexico, it could pick up international passengers who fly into several U.S. gateways for flights across the country. Southwest Airlines Co. (NYSE:LUV) belongs to Services sector. Its net…

Read More

Small Cap Stocks: Universal Display Corporation (NASDAQ:OLED), Heritage-Crystal Clean (NASDAQ:HCCI), IPC The Hospitalist (NASDAQ:IPCM), Dyax Corp. (NASDAQ:DYAX), Lightinthebox Holding (NYSE:LITB)

Jason Knox03 mins

Goldman, a long-time Universal Display Corporation (NASDAQ:OLED)) bull, has issued another upbeat note: The firm sees a variety of upcoming mobile, TV, and wearables product launches boosting Universal’s growth.Goldman recently argued Samsung’s new Galaxy Tab S (features a 2K OLED display) will act as a positive catalyst; volumes should be much lower than the Galaxy…

Read More

Biotech Insider Selling: Achillion Pharmaceuticals (NASDAQ:ACHN), MannKind Corporation (NASDAQ:MNKD), Questcor Pharmaceuticals Inc (NASDAQ:QCOR), Dyax Corp. (NASDAQ:DYAX), Illumina (NASDAQ:ILMN)

Kristen Barton03 mins

Achillion Pharmaceuticals, Inc (NASDAQ:ACHN) Director Gary E. Frashier unloaded 55,000 shares of the stock on the open market in a transaction that occurred on Monday, June 16th. The shares were sold at an average price of $8.00, for a total transaction of $440,000.00. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stock performance was -3.07% in last session and…

Read More
Gilead Sciences GILD NASDAQ:GILD

Biotech GAiners: BioCryst Pharmaceuticals (NASDAQ:BCRX), Dyax Corp. (NASDAQ:DYAX), Novavax, Inc. (NASDAQ:NVAX), Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

Kevin Long02 mins

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares closed up nearly 11% on Tuesday after the company reported positive data from its OPuS-1 mid-stage study involving BCX4161 as a treatment for hereditary angioedema, or HAE. This is a rare immune disorder that can cause swelling of the face, breathing airways, and also causes abdominal cramping. According to the…

Read More

Biotech Most Volatile: Celldex Therapeutics (NASDAQ:CLDX), Dyax Corp. (NASDAQ:DYAX), Insmed Incorporated (NASDAQ:INSM), Novavax (NASDAQ:NVAX)

Chris Lewis02 mins

Celldex Therapeutics Inc. (NASDAQ:CLDX) options contracts experienced a new 90-day record for call contracts where a total of 5,803 call contracts were traded in the busy trading session. The contract spread yielded a 0.58 put/call ratio where 1.7 call contracts were traded for each put contract. Celldex Therapeutics, Inc. (NASDAQ:CLDX) stock performance was 0.07% in…

Read More